At close: December 27 at 5:30:17 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 19 | 18 |
| Avg. Estimate | 0 | 0 | 7.9 | 8.57 |
| Low Estimate | 0 | 0 | 7.13 | 7.57 |
| High Estimate | 0 | 0 | 8.98 | 10.22 |
| Year Ago EPS | -- | -- | 7.27 | 7.9 |
Revenue Estimate
| Currency in CHF | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 20 | 19 |
| Avg. Estimate | 2.78B | -- | 11.74B | 12.22B |
| Low Estimate | 2.78B | -- | 11.59B | 11.89B |
| High Estimate | 2.78B | -- | 12.11B | 12.84B |
| Year Ago Sales | 2.79B | -- | 11.24B | 11.74B |
| Sales Growth (year/est) | -0.34% | -- | 4.45% | 4.12% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 7.9 | 8.57 |
| 7 Days Ago | 0 | 0 | 7.92 | 8.63 |
| 30 Days Ago | 0 | 0 | 7.94 | 8.68 |
| 60 Days Ago | 0 | 0 | 8.05 | 8.93 |
| 90 Days Ago | 0 | 0 | 8.16 | 9.21 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | 3 | 3 |
| Down Last 30 Days | -- | -- | 5 | 6 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SIKA.SW | -- | -- | 8.66% | 8.54% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Related Tickers
GIVN.SW Givaudan SA
3,982.00
+0.84%
DSFIR.AS DSM-Firmenich AG
97.68
-0.27%
EMSN.SW EMS-CHEMIE HOLDING AG
613.00
+0.74%
CLN.SW Clariant AG
10.10
+1.61%
GURN.SW Gurit Holding AG
15.18
+9.68%
LIN.DE Linde plc
407.20
+1.14%
ZX6.DU DSM-Firmenich AG
98.06
+0.62%
AKZA.AS Akzo Nobel N.V.
56.64
+0.82%
AKE.PA Arkema S.A.
71.60
+0.85%
ALCRB.PA Carbios SAS
7.00
+3.70%